Edwards Lifesciences Corp (EW)vsViemed Healthcare Inc (VMD)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
VMD
Viemed Healthcare Inc
$9.35
+1.63%
HEALTHCARE · Cap: $354.37M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 2145% more annual revenue ($6.07B vs $270.28M). EW leads profitability with a 17.7% profit margin vs 5.5%. VMD trades at a lower P/E of 24.8x. VMD earns a higher WallStSmart Score of 56/100 (C).
EW
Buy55
out of 100
Grade: C
VMD
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Margin of Safety
+51.2%
Fair Value
$17.32
Current Price
$9.35
$7.97 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
Revenue surging 25.5% year-over-year
Earnings expanding 29.8% YoY
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Smaller company, higher risk/reward
5.5% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : VMD
The strongest argument for VMD centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 25.5% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : VMD
The primary concerns for VMD are Market Cap, Profit Margin.
Key Dynamics to Monitor
EW profiles as a mature stock while VMD is a growth play — different risk/reward profiles.
VMD carries more volatility with a beta of 1.23 — expect wider price swings.
VMD is growing revenue faster at 25.5% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
VMD scores higher overall (56/100 vs 55/100) and 25.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Viemed Healthcare Inc
HEALTHCARE · MEDICAL DEVICES · USA
Viemed Healthcare, Inc. provides durable home medical equipment and post-acute respiratory health care services to patients in the United States. The company is headquartered in Lafayette, Louisiana.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?